About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
PhRMA submitted post-hearing comments pursuant to the Section 301 investigation into Brazil’s acts, policies and practices. These comments are intended to elaborate on the responses provided during the hearing to the questions posed by the Section 301 Committee and focus on two longstanding, systemic and discriminatory intellectual property barriers in Brazil that burden or restrict U.S. commerce and harm biopharmaceutical innovation.
PhRMA Submits Post-hearing Comments in Brazil Section 301 Investigation teaser
Comment
Intellectual Property
International
Trade
PhRMA Submits Post-hearing Comments in Brazil Section 301 Investigation
PhRMA Submits Post-hearing Comments in Brazil Section 301 Investigation teaser